152 related articles for article (PubMed ID: 35970223)
21. Design, synthesis and antiproliferative activity of functionalized flavone-triazole-tetrahydropyran conjugates against human cancer cell lines.
Ahmed N; Konduru NK; Ahmad S; Owais M
Eur J Med Chem; 2014 Jul; 82():552-64. PubMed ID: 24941129
[TBL] [Abstract][Full Text] [Related]
22. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
23. Anticancer activity of novel 3-(furan-2-yl)pyrazolyl and 3-(thiophen-2-yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies.
Helmy MT; Sroor FM; Mahrous KF; Mahmoud K; Hassaneen HM; Saleh FM; Abdelhamid IA; Mohamed Teleb MA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100381. PubMed ID: 34939695
[TBL] [Abstract][Full Text] [Related]
24. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of Flavone Derivatives via
Zhang N; Yang J; Li K; Luo J; Yang S; Song JR; Chen C; Pan WD
Molecules; 2019 Jul; 24(15):. PubMed ID: 31357486
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt.
Abo-Salem HM; Gibriel AA; El Awady ME; Mandour AH
Med Chem; 2021; 17(2):158-170. PubMed ID: 32141421
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic Effects on Breast Cancer Cell Lines of Chalcones Derived from a Natural Precursor and Their Molecular Docking Analysis.
Bustos L; Echiburú-Chau C; Castro-Alvarez A; Bradshaw B; Simirgiotis MJ; Mellado M; Parra C; Cuellar M
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889260
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship.
Shenvi S; Kumar K; Hatti KS; Rijesh K; Diwakar L; Reddy GC
Eur J Med Chem; 2013 Apr; 62():435-42. PubMed ID: 23395966
[TBL] [Abstract][Full Text] [Related]
29. New Hybrid Scaffolds Based on Carbazole-Chalcones as Potent Anticancer Agents.
Rashid F; Zaib S; Ibrar A; Ejaz SA; Saeed A; Iqbal J; Khan I
Anticancer Agents Med Chem; 2021; 21(9):1082-1091. PubMed ID: 32698741
[TBL] [Abstract][Full Text] [Related]
30. Chalcones: Potential Chemotherapeutic Compounds and Educational Tools for Closing the Loop in STEM.
Russell AE; Gines BR
Acc Chem Res; 2023 Jun; 56(11):1256-1262. PubMed ID: 36696370
[TBL] [Abstract][Full Text] [Related]
31. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities.
Kant R; Kumar D; Agarwal D; Gupta RD; Tilak R; Awasthi SK; Agarwal A
Eur J Med Chem; 2016 May; 113():34-49. PubMed ID: 26922227
[TBL] [Abstract][Full Text] [Related]
33. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Thillainayagam M; Malathi K; Ramaiah S
J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
35. New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
Castaño LF; Cuartas V; Bernal A; Insuasty A; Guzman J; Vidal O; Rubio V; Puerto G; Lukáč P; Vimberg V; Balíková-Novtoná G; Vannucci L; Janata J; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
Eur J Med Chem; 2019 Aug; 176():50-60. PubMed ID: 31096118
[TBL] [Abstract][Full Text] [Related]
36. Enhanced susceptibility to apoptosis and growth arrest of human breast carcinoma cells treated with silica nanoparticles loaded with monohydroxy flavone compounds.
Abo El-Maali N; Badr G; Sayed D; Adam R; Abd El Wahab G
Biochem Cell Biol; 2019 Oct; 97(5):513-525. PubMed ID: 30640511
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, Structure and In Vitro Cytotoxic Activity of Novel Cinchona-Chalcone Hybrids with 1,4-Disubstituted- and 1,5-Disubstituted 1,2,3-Triazole Linkers.
Jernei T; Duró C; Dembo A; Lajkó E; Takács A; Kőhidai L; Schlosser G; Csámpai A
Molecules; 2019 Nov; 24(22):. PubMed ID: 31718009
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationship studies of furan-ring fused chalcones as antiproliferative agents.
Saito Y; Kishimoto M; Yoshizawa Y; Kawaii S
Anticancer Res; 2015 Feb; 35(2):811-7. PubMed ID: 25667461
[TBL] [Abstract][Full Text] [Related]
39. Relationship Between the Structure of Methoxylated and Hydroxylated Flavones and Their Antiproliferative Activity in HL60 Cells.
Kawaii S; Ishikawa Y; Yoshizawa Y
Anticancer Res; 2018 Oct; 38(10):5679-5684. PubMed ID: 30275187
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives.
Ngameni B; Cedric K; Mbaveng AT; Erdoğan M; Simo I; Kuete V; Daştan A
Bioorg Med Chem Lett; 2021 Mar; 35():127827. PubMed ID: 33508467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]